Healthcare provider profile · identity verified

Stephen C Mills, MD

Family Practice · LATROBE, PA · NPI 1942255989

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	497	138
Pantoprazole Sodium	Pantoprazole Sodium	378	107
Levothyroxine Sodium	Levothyroxine Sodium	351	84
Rosuvastatin Calcium	Rosuvastatin Calcium	317	98
Amlodipine Besylate	Amlodipine Besylate	299	83
Losartan Potassium	Losartan Potassium	282	75
Atenolol	Atenolol	251	65
Omeprazole	Omeprazole	249	76
Metformin Hcl	Metformin Hcl	244	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	242	30
Lisinopril	Lisinopril	239	68
Gabapentin	Gabapentin	237	57
Simvastatin	Simvastatin	216	56
Trulicity	Dulaglutide	190	26
Albuterol Sulfate Hfa	Albuterol Sulfate	183	44
Metoprolol Tartrate	Metoprolol Tartrate	173	51
Meloxicam	Meloxicam	171	59
Metformin Hcl Er	Metformin Hcl	166	45
Hydrochlorothiazide	Hydrochlorothiazide	164	43
Furosemide	Furosemide	161	55
Tamsulosin Hcl	Tamsulosin Hcl	159	41
Fluticasone Propionate	Fluticasone Propionate	143	48
Jardiance	Empagliflozin	136	28
Pravastatin Sodium	Pravastatin Sodium	130	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	119	21
Metoprolol Succinate	Metoprolol Succinate	117	31
Baclofen	Baclofen	114	29
Ventolin Hfa	Albuterol Sulfate	114	21
Xarelto	Rivaroxaban	106	24
Glimepiride	Glimepiride	102	27
Allopurinol	Allopurinol	97	23
Clopidogrel	Clopidogrel Bisulfate	97	35
Prednisone	Prednisone	93	42
Montelukast Sodium	Montelukast Sodium	89	24
Citalopram Hbr	Citalopram Hydrobromide	84	21
Finasteride	Finasteride	84	23
Escitalopram Oxalate	Escitalopram Oxalate	82	26
Lorazepam	Lorazepam	82	13
Potassium Chloride	Potassium Chloride	82	21
Carvedilol	Carvedilol	80	21
Tramadol Hcl	Tramadol Hcl	73	14
Famotidine	Famotidine	71	24
Alprazolam	Alprazolam	67	suppressed
Celecoxib	Celecoxib	67	22
Mirtazapine	Mirtazapine	67	18
Incruse Ellipta	Umeclidinium Bromide	62	17
Ondansetron Hcl	Ondansetron Hcl	62	18
Azithromycin	Azithromycin	60	50
Diclofenac Sodium	Diclofenac Sodium	60	21
Ozempic	Semaglutide	60	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	59	44
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	11
Zolpidem Tartrate	Zolpidem Tartrate	55	12
Duloxetine Hcl	Duloxetine Hcl	53	17
Sertraline Hcl	Sertraline Hcl	51	15
Spiriva Respimat	Tiotropium Bromide	51	11
Eliquis	Apixaban	50	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Synthroid	Levothyroxine Sodium	45	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Mupirocin	Mupirocin	44	21
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Meclizine Hcl	Meclizine Hcl	43	17
Fluconazole	Fluconazole	41	23
Farxiga	Dapagliflozin Propanediol	40	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	32
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Propranolol Hcl Er	Propranolol Hcl	37	suppressed
Betamethasone Valerate	Betamethasone Valerate	36	21
Cephalexin	Cephalexin	35	23
Doxycycline Hyclate	Doxycycline Hyclate	35	21
Propranolol Hcl	Propranolol Hcl	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	12
Pregabalin	Pregabalin	34	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	32	suppressed
Linzess	Linaclotide	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Naproxen	Naproxen	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Nystatin	Nystatin	27	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Methylprednisolone	Methylprednisolone	24	22
Nitroglycerin	Nitroglycerin	23	14
Novolog Flexpen	Insulin Aspart	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Cefdinir	Cefdinir	19	17
Clindamycin Phosphate	Clindamycin Phosphate	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	11
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Clindamycin Hcl	Clindamycin Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Metolazone	Metolazone	18	suppressed
Potassium Citrate Er	Potassium Citrate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Glipizide	Glipizide	17	suppressed
Nadolol	Nadolol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Repaglinide	Repaglinide	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	11
Valacyclovir	Valacyclovir Hcl	15	suppressed
Ibu	Ibuprofen	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Chlorzoxazone	Chlorzoxazone	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Digoxin	Digoxin	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error